rolofylline has been researched along with Anasarca in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Edwards, C; Givertz, MM; Massie, BM; Metra, M; Milo, O; O'Connor, CM; Ponikowski, P; Senger, S; Teerlink, JR; Voors, AA | 1 |
Karasawa, A; Kusaka, H; Nagashima, K | 1 |
2 other study(ies) available for rolofylline and Anasarca
Article | Year |
---|---|
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Topics: Acute Disease; Aged; Comorbidity; Diabetes Mellitus; Disease Progression; Diuretics; Edema; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Patient Readmission; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency; Severity of Illness Index; Xanthines | 2016 |
Effects of KW-3902, an adenosine A1-receptor antagonist, on ascites volume in puromycin aminonucleoside (PAN)-induced nephrotic rats.
Topics: Animals; Ascites; Diuretics; Edema; Furosemide; Male; Nephrosis; Purinergic P1 Receptor Antagonists; Puromycin Aminonucleoside; Rats; Rats, Wistar; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Xanthines | 1995 |